KalVista Pharmaceuticals Limited
Business
Biopharmaceutical Company
Team
250+ colleagues
Location
Salisbury, Wiltshire, UK
Being able to offer Electric cars at a huge discount is a great addition to our growing suite of benefits for working at our company!
— Catherine O’Brien, Finance Director at KalVista Pharmaceuticals Limited
KalVista Pharmaceuticals Limited is a global biopharmaceutical company and a specialist in developing and delivering life-changing oral therapies for individuals affected by rare diseases with significant unmet needs. Founded in 2011 and headquartered across three sites in Salisbury (UK), Cambridge (Massachusetts), and Salt Lake City (Utah), the company has built world-leading expertise in the kallikrein-kinin system and small molecule protease inhibitors.
With a team of more than 250 employees worldwide, KalVista is dedicated to advancing rigorous science to better address treatment needs for patients living with hereditary angioedema (HAE), a rare genetic disease characterised by unpredictable and debilitating attacks of tissue swelling that can be life-threatening. The company's flagship product, EKTERLY® (sebetralstat), was discovered in their Salisbury laboratories and has been approved by the FDA and UK MHRA as the first and only oral on-demand treatment for HAE attacks in adults and adolescents aged 12 years and older, with regulatory applications under review in key global markets including the EU and Japan, positioning KalVista to transform HAE treatment worldwide.
If you would like to learn more about The Electric Car Scheme, visit our website which explains how electric car salary sacrifice can work for your company.
To be eligible for a Drive Day, your company must have more than 70 employees. This criterion is essential to guarantee an ample number of participants interested in driving the available vehicles, given the significant time and resources required for event organisation and funding. This is subject to approval and the final decision will be made by the team at The Electric Car Scheme
